Scripps Research scientists receive up to $12M to create universal vaccine for alphaviruses Funding from ARPA-H will be used to develop a vaccine for alphaviruses in preparation of major outbreaks in the U.S.
December 04, 2024
LA JOLLA, CA Alphaviruses often cause a range of illnesses that lead to fever, rash and debilitating joint pain. While they're historically prevalent in tropical and subtropical regions of the world where virus-transmitting mosquitos are abundant, these mosquitos are expanding to new terrain including the U.S. as global warming intensifies. Alphavirus diseases like eastern equine encephalitis, which inflames the brain and can lead to death, are among the country's emerging threats against which no human vaccine is available.
Despite various efforts in the works to develop vaccines for specific alphaviruses, there's currently no universal vaccine to broadly target a range of virus strains. That means as alphaviruses become more widespread, people will need several jabs rather than one assuming specific vaccines become available.
Now, a collaboration among Scripps Research, Vanderbilt University and others has been awarded more than $46 million from the Advanced Research Projects Agency for Health (ARPA-H), a research funding agency of the U.S. government, to develop a universal vaccine against alphaviruses. Scripps Research will receive up to $12 million for its contribution to the project, which is expected to last five years.
The principal investigators at Scripps Research include Torben Schiffner, PhD, who leads immunogen design at the institute; Darrell Irvine, PhD, a professor in the Department of Immunology and Microbiology; Andrew Ward, PhD, a professor in the Department of Integrative Structural and Computational Biology; and Ian Wilson, PhD, who chairs the Department of Integrative Structural and Computational Biology and is the Hansen Professor of Structural Biology.
This award combines experts in artificial intelligence (AI) with vaccinologists to accomplish a great deal over a short time span, says Schiffner, who is the lead principal investigator on the award at Scripps Research. We're going to hear a lot more about alphaviruses in the future, and there already have been minor outbreaks in the U.S.
The money from ARPA-H will fund a two-stage project: After a three-year preclinical stage to create an immunogen candidate, the molecule will enter a phase 1 clinical trial for two years if it performs well preclinically. An immunogen is a substance that activates the immune system, helping the body recognize and fight harmful agents like viruses. This is a primary step in vaccine development, as scientists design an immunogen to mimic parts of a virus that way, when the resulting vaccine is administered, the body can learn how to defend itself even if it has never been exposed to the actual virus.
The principal investigators at Scripps Research plan to synergize their deep-seated knowledge in vaccinology with AI-expertise at other institutes, chiefly Vanderbilt University. Collaborators at Vanderbilt University Medical Center will isolate alphavirus antibodies from people who have survived alphavirus-related infections, particularly those that protect against different alphaviruses. The team at Scripps Research will use these antibodies to guide vaccine design. Initially, they will determine the structure of antibodies and how they bind to alphaviruses.
We need to understand where broadly protective antibodies attack and bind to the virus, Schiffner says. We can then use this information to design immunogens that focus antibodies onto regions conserved across alphaviruses.
The team has already identified several such cross-protective antibodies, providing valuable blueprints for immunogen design.
Normally, if you try to immunize with an entire virus, most of the antibodies will target regions that aren't conserved among different viruses, so you get a vaccine that only works for a particular strain, Schiffner explains. There are very few regions that seem to be conserved across alphaviruses, and those are the regions that we want to target for broad protection against all alphaviruses.
Next is testing various immunogen designs with computer models that include AI algorithms. If a design seems promising, it's tested in vitro and in vivo.
But the role of AI doesn't end there; data from ensuing in vitro and in vivo experimentation are fed back to the AI system, which can rapidly analyze antibody sequences, determine whether the immunogen is focusing antibodies on regions conserved across variants, and provide improved algorithms for reoptimizing the vaccine design.
We'll find out if the antibodies actually target the regions that they're supposed to, Schiffner says. And once we get the AI results, we can use the information to improve our immunogen before the next stages; it's an iterative process.
The anticipated result: a broad vaccine that targets both encephalitic and arthritogenic alphaviruses that cause brain or joint inflammation, respectively. Moreover, the algorithms developed for this project could potentially be applied to other viruses, including influenza and HIV.
But the main goal is to have an effective, broad vaccines for alphaviruses before they become a major problem. emphasizes Schiffner.
Immunology & Microbiology Integrative Structural & Computational Biology
Most recent headlines
05/01/2027
Worlds first 802.15.4ab-UWB chip verified by Calterah and Rohde & Schwarz to be ...
09/10/2026
Share
Copy link
Facebook
X
Linkedin
Bluesky
Email...
09/10/2026
Share
Copy link
Facebook
X
Linkedin
Bluesky
Email...
09/10/2026
Share
Copy link
Facebook
X
Linkedin
Bluesky
Email...
09/10/2026
September 10 2026, 06:00 (PDT) Dolby Expands Dolby OptiView Platform with New Capabilities at IBC 2026
New Sports Intelligence helps providers better unders...
08/10/2026
Modern venues have come a long way since the tinny, echoing audio of the mid 20t...
08/10/2026
ESPN's first Super Bowl production will stream in English and Spanish on Disney+, while the ESPN App carries the full slate of game, ManningCast, studio, an...
08/10/2026
From high-school videoboards to War Eagle Productions, the Opelika native is learning how to lead shows and capture big moments
The future of live sports produ...
08/10/2026
The Television Academy and Prime Video have announced a six-year agreement making Prime Video the exclusive global home of the Emmy Awards beginning with the 20...
08/10/2026
Techex will exhibit at NAB Show New York 2026 (Booth 623, Javits Center, October...
08/10/2026
X Games has announced the appointment of Steve Rogers as Chief Operating Officer. Rogers previously served as COO of World Supercross and spent nearly a decade ...
08/10/2026
Fonn Group has appointed Trevor Spielmann as Sales Director for Germany, Austria, and Switzerland. Spielmann joins from EVS, where he held sales and business de...
08/10/2026
The flagship program will originate from major PG events with a four-camera production, live distribution across PGTV, social platforms
Perfect Game is bringin...
08/10/2026
Innovation rarely happens in a vacuum. More often, it happens at the point of collision: when worlds that have run on separate tracks begin to converge. That is...
08/10/2026
For decades, the production and broadcast services business has run on a familia...
08/10/2026
Uplynk, Zixi, BroadView Software, and Grass Valley have published The IP Converg...
08/10/2026
The NFL has announced the return of the Big Data Bowl, the league's analytics competition, now in its ninth year and again powered by AWS. Registration is o...
08/10/2026
Eutelsat has renewed its partnership with T l diffusion d'Alg rie (TDA), Algeria's national broadcasting network operator, for continued distribution of...
08/10/2026
Disney will livestream Super Bowl LXI on February 14, 2027, alongside the game's broadcast on ESPN and ABC. All Disney subscribers in the United States wi...
08/10/2026
RHStv and Red House Streaming have announced an expansion of their partnership w...
08/10/2026
Gray Media has announced a distribution agreement with TEGNA and DAZN to simulca...
08/10/2026
SVG readers can save 10% on registration and receive a complimentary Solutions H...
08/10/2026
PROTON Camera Innovations GmbH has been named a recipient of a 2026 Technology a...
08/10/2026
Industry leaders discuss real-world cloud workflows for live game production, pl...
08/10/2026
The next-gen audio technology joins Dolby Vision as part of Apple TV's immersive F1 experience...
08/10/2026
David France, Jesse Short Bull, Mato Wayuhi, N. Bird Runningwater, Jodi Archambau, Jhane Myers, Paul McGuire, Amber Morning Star Byars, Holly Macarro, Nick Tils...
08/10/2026
Dynamic panning plug-ins get an upgrade
Sound Particles have just announced major updates for two of their popular dynamic panning plug-ins. Energy Panner 2...
08/10/2026
New expandable instrument boasts full DMNO engine
UDO Audio have just announced the upcoming release of a new, expandable synth that packs the power of the ...
08/10/2026
Two new subwoofers added to monitoring line-up
ADAM Audio's monitoring range has just been expanded with two new DSP-equipped subwoofers, the Sub8 PRO a...
08/10/2026
eds3_5_jq(document).ready(function($) { $(#eds_sliderM519).chameleonSlider_2_1({ content_source:......
08/10/2026
Calrec gives broadcasters freedom of choice at NAB Show New York We're looking forward to meeting up with you all at NAB New York on 21st-22nd October.
Cal...
08/10/2026
Share
Copy link
Facebook
X
Linkedin
Bluesky
Email...
08/10/2026
Share
Copy link
Facebook
X
Linkedin
Bluesky
Email...
08/10/2026
Share
Copy link
Facebook
X
Linkedin
Bluesky
Email...
08/10/2026
Share
Copy link
Facebook
X
Linkedin
Bluesky
Email...
08/10/2026
Share
Copy link
Facebook
X
Linkedin
Bluesky
Email...
08/10/2026
Share
Copy link
Facebook
X
Linkedin
Bluesky
Email...
08/10/2026
Globecast, a leading provider of broadcast, media and entertainment managed services, will showcase its next generation of media orchestration services at NAB S...
08/10/2026
Clear-Com played a critical role in the production communications infrastructure for Rock in Rio 2026, one of the world's largest and most recognized music...
08/10/2026
Sohonet Launches ClearView Rush: A Leap Forward in Studio Review, Built for Crea...
08/10/2026
Share
Copy link
Facebook
X
Linkedin
Bluesky
Email...
08/10/2026
Share
Copy link
Facebook
X
Linkedin
Bluesky
Email...
08/10/2026
Share
Copy link
Facebook
X
Linkedin
Bluesky
Email...
08/10/2026
Share
Copy link
Facebook
X
Linkedin
Bluesky
Email...
08/10/2026
Ikegami announces a major expansion to its range of broadcast-quality live production cameras. Scheduled for introduction on Ikegami booth 708 at NAB New York, ...
08/10/2026
Calrec will be located at Booth 444.
Freedom to choose
The media landscape is evolving quickly, and the broadcasters best placed for what comes next will be...
08/10/2026
LiveU has announced that CRD Audiovisuel relied on LiveUs LU900Q intelligent production unit, with built-in native LiveU IQ (LIQ ) connectivity, to deliver live...
08/10/2026
Share
Copy link
Facebook
X
Linkedin
Bluesky
Email...
08/10/2026
Share
Copy link
Facebook
X
Linkedin
Bluesky
Email...
Scripps Research scientists receive up to $12M to create universal vaccine for alphaviruses Funding from ARPA-H will be used to develop a vaccine for alphaviruses in preparation of major outbreaks in the U.S.
